Home / Pantoprazole / Canada
CA ATC A02BC02 · updated 2 Nov 2026
Pantoprazole shortage in Canada
Is there a Pantoprazole shortage in Canada?
Yes. As of 2 Nov 2026, 13 Pantoprazole products are reported short in Canada, the first since 1 Jan 2020. The company estimate for the return is 11 Dec 2026 (latest 15 Feb 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Austria, Belgium, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | JAMP-PANTOPRAZOLE (100) | JAMP PHARMA CORPORATION | 1 Jan 2020 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-PANTOPRAZOLE (100 & 500) | TEVA CANADA LIMITED | 8 Nov 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-PANTOPRAZOLE (100) | TEVA CANADA LIMITED | 6 Mar 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PANTOPRAZOLE (100) | SANIS HEALTH INC | 11 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-PANTOPRAZOLE MAGNESIUM (100) limited | TEVA CANADA LIMITED | 17 Sep 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PANTOPRAZOLE T (500) | SANIS HEALTH INC | 8 Dec 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-PANTOPRAZOLE T (100 BTL) | MYLAN PHARMACEUTICALS ULC | 22 Dec 2025 | 9 Feb 2027 | Increased demand Demand increase for the drug |
| CA | PANTOPRAZOLE T (500) | SANIS HEALTH INC | 29 Apr 2026 | 8 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PANTOPRAZOLE MAGNESIUM (100) | SIVEM PHARMACEUTICALS ULC | 1 Jun 2026 | 1 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-PANTOPRAZOLE (500 BTL) | APOTEX INC | 22 Sep 2026 | 22 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TECTA (Blisters - 30 count) limited | TAKEDA CANADA INC | 26 Oct 2026 | 18 Dec 2026 | Increased demand Demand increase for the drug |
| CA | SANDOZ PANTOPRAZOLE (100GRT) | SANDOZ CANADA INCORPORATED | 2 Nov 2026 | 11 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PANTOPRAZOLE FOR INJECTION (40 mg) discontinuation | FRESENIUS KABI CANADA LTD | not given | 15 Feb 2027 | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.